Assessment of the relationship between non-alcoholic fatty liver disease and diabetic complications

Journal of Diabetes Investigation

Volumn 7, Issue 6, 2016, Pages 889-894

  Yan, Li Hui ^a   Mu, Biao ^a   Guan, Yue ^a   Liu, Xinyu ^a   Zhao, Nan ^a   Pan, Da ^a   Wang, Shao Zhen ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Diabetic complication; Non alcoholic fatty liver disease; Type 2 diabetes

Indexed keywords

GLYCOSYLATED HEMOGLOBIN;

ABDOMINAL RADIOGRAPHY; ADULT; ALBUMINURIA; ARTICLE; BLOOD PRESSURE MEASUREMENT; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DISEASE DURATION; DOPPLER FLOWMETRY; ECHOCARDIOGRAPHY; ECHOGRAPHY; ELECTROPHYSIOLOGY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; INCIDENCE; KIDNEY FUNCTION TEST; LIPID BLOOD LEVEL; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; OPHTHALMOSCOPY; ORAL GLUCOSE TOLERANCE TEST; PERIPHERAL NEUROPATHY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; COMPLICATION; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; DIAGNOSTIC IMAGING; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE;

CORONARY ARTERY DISEASE; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; DIABETIC RETINOPATHY; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE;

EID: 84994108046     PISSN: 20401116     EISSN: 20401124     Source Type: Journal    
DOI: 10.1111/jdi.12518     Document Type: Article

References (35)

1. Adams LA, Angulo P, Lindor KD. Nonalcoholic fatty liver disease. CMAJ 2005; 172: 899–905.
2. Hou XH, Zhu YX, Lu HJ, et al. Non-alcoholic fatty liver disease's prevalence and impact on alanine aminotransferase associatedwith metabolic syndrome in the Chinese. J Gastroenterol Hepatol 2011; 26: 722–730.
3. Fan JG, Saibara T, Chitturi S, et al. What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific. J Gastroenterol Hepatol 2007; 22: 794–800.
4. Amarapurkar DN, Hashimoto E, Lesmana LA, et al. How common is non–alcoholic fatty liver disease in the Asia–Pacific region and are there local differences. J Gastroenterol Hepatol 2007; 22: 788–793.
5. Fan JG, Farrell GC. Epidemiology of non–alcoholic fatty liver disease in China. J Hepatol 2009; 50: 204–210.
6. Akbar DH, Kawther AH. Nonalcoholic fatty liver disease in Saudi type 2 diabetic subjects attending a medical outpatient clinic: Prevalence and general characteristics. Diabetes Care 2003; 26: 3351–3352.
7. Gupte P, Amarapurkar D, Agal S, et al. Non-alcoholic steatohepatitis in type 2 diabetes mellitus. J Gastroenterol Hepatol 2004; 19: 854–858.
8. Leite NC, Salles GF, Araujo AL, et al. Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus. Liver Int 2009; 29: 113–119.
9. Younossi ZM, Gramlich T, Matteoni CA, et al. Nonalcoholic fatty liver disease in patients with type 2 diabetes. Clin Gastroenterol Hepatol 2004; 2: 262–265.
10. Targher G, Bertolini L, Padovani R, et al. Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care 2007; 30: 1212–1218.
11. Kim CH, Park JY, Lee KU, et al. Fatty liver is an independent risk factor for the development of Type 2 diabetes in Korean adults. Diabet Med 2008; 25: 476–481.
12. El Azeem H, Khalek E-S, El-Akabawy H. Association between nonalcoholic fatty liver disease and the incidence of cardiovascular and renal events. J Saudi Heart Assoc 2013; 25: 239–246.
13. Sung KC, Wild SH, Kwag HJ, et al. Fatty liver, insulin resistance, and features of metabolic syndrome: Relationships with coronary artery calcium in 10,153 people. Diabetes Care 2012; 35: 2359–2364.
14. Targher G, Bertolini L, Padovani R, et al. Non-alcoholic fatty liver disease is associated with carotid artery wall thickness in diet-controlled type 2 diabetic patients. J Endocrinol Investig 2006; 29: 55–60.
15. Targher G, Bertolini L, Padovani R, et al. Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease. Diabetes Care 2006; 29: 1325–1330.
16. Kim HC, Kim DJ, Huh KB. Association between nonalcoholic fatty liver disease and carotid intima-media thickness according to the presence of metabolic syndrome. Atherosclerosis 2009; 204: 521–525.
17. Bonapace S, Perseghin G, Molon G, et al. Nonalcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in patients with type 2 diabetes. Diabetes Care 2012; 35: 389–395.
18. Targher G, Byrne CD. Clinical Review: Nonalcoholic fatty liver disease: A novel cardiometabolic risk factor for type 2 diabetes and its complications. J Clin Endocrinol Metab 2013; 98: 483–495.
19. Targher G, Kendrick J, Smits G, et al. Relationship between serum gamma-glutamyltransferase and chronic kidney disease in the United States adult population. Findings from the National Health and Nutrition Examination Survey 2001–2006. Nutr Metab Cardiovasc Dis 2010; 20: 583–590.
20. Speliotes EK, Massaro JM, Hoffmann U, et al. Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: The Framingham Heart Study. Hepatology 2010; 51: 1979–1987.
21. Fraser A, Harris R, Sattar N, et al. Alanine aminotransferase, gamma-glutamyltransferase, and incident diabetes: The British Women's Heart and Health Study and meta-analysis. Diabetes Care 2009; 32: 741–750.
22. Musso G, Gambino R, Cassader M, et al. Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med 2011; 43: 617–649.
23. Xie Y, Wang M, Zhang Y, et al. Serum uric acid and non-alcoholic fatty liver disease in non-diabetic Chinese men. PLoS ONE 2013; 8: e67152.
24. Masahide H, Takao K, Noriyuli T, et al. Nonalcoholic fattyliver disease is a novel predictor of cardiovascular disease. Gastroenterology 2007; 13: 1579–1584.
25. Targher G, Bertolini L, Scala L, et al. Non-alcoholic hepatic steatosis and its relation to increased plasma biomarkers of inflammation and endothelial dysfunction in non-diabetic men. Role of visceral adipose tissue. Diabet Med 2005; 22: 1354–1358.
26. Yan L, Wang S, Fu Y, et al. The impact of non-alcoholic fatty liver disease on islet function in type 2 diabetes. Zhonghua Nei Ke Za Zhi 2015; 54: 197–200.
27. Wu SJ, Zou H, Zhu GQ, et al. Increased Levels of Systolic Blood Pressure Within the Normal Range Are Associated With Significantly Elevated Risks of Nonalcoholic Fatty Liver Disease. Medicine (Baltimore). 2015; 94: e842.
28. Aneni EC, Oni ET, Martin SS, et al. Blood pressure is associated with the presence and severity of nonalcoholic fatty liver disease across the spectrum of cardiometabolic risk. J Hypertens 2015; 33: 1207–1214.
29. Sung KC, Wild SH, Byrne CD. Development of new fatty liver, or resolution of existing fatty liver, over five years of follow-up, and risk of incident hypertension. J Hepatol 2014; 60: 1040–1045.
30. Latea L, Negrea S, Bolboaca S. Primary non-alcoholic fatty liver disease in hypertensive patients. Australas Med J 2013; 6: 325–330.
31. Paschos P, Tziomalos K. Nonalcoholic fatty liver disease and the renin-angiotensin system: Implications for treatment. World J Hepatol 2012; 4: 327–331.
32. Huh JH, Ahn SV, BaekKoh S, et al. A prospective study of fatty liver index and incident hypertension: The KoGES-ARIRANG Study. PLoS ONE 2015; 10: e0143560.
33. Lv W-S, Sun R-X, Gao Y-Y, et al. Nonalcoholic fatty liver disease and microvascular complications in type 2 diabetes. World J Gastroenterol 2013; 19: 3134–3142.
34. Kim BY, Jung CH, Mok JO, et al. Prevalences of diabetic retinopathy and nephropathy are lower in Korean type 2 diabetic patients with non-alcoholic fatty liver disease. J Diabetes Investig 2014; 5: 170–175.
35. Targher G, Bertolini L, Rodella S, et al. Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/laser-treated retinopathy in type 2 diabetic patients. Diabetologia 2008; 51: 444–450.